Tag: Tessa Munt

The below Parliamentary question was asked by Tessa Munt on 2014-06-13.

To ask the Secretary of State for Health, whether guidance issued by Monitor is mandatory for NHS England to follow.

Jane Ellison

It is the National Health Service (Procurement, Patient Choice and Competition) (No.2) Regulations 2013 that place requirements on NHS England, including requirements as to good practice in relation to procurement.

Enforcement of the procurement requirements by Monitor may only follow its investigation of a complaint that there has been a failure by a commissioner to comply with the requirements. Guidance issued by Monitor on the regulations, including guidance issued in April, provides advice for commissioners on compliance with the regulations.

The below Parliamentary question was asked by Tessa Munt on 2014-05-01.

To ask the Secretary of State for Health, with reference to section 2 of the guidance issued by Monitor on the Commissioning of Radiosurgery Services on 4 April 2014, if he will request that NHS England reinstates the commissioning of stereotactic radiotherapy to the level before 1 April 2013 while it conducts its review into the future use of this treatment.

Jane Ellison

All existing contracts for stereotactic radiotherapy services were transferred to NHS England on 1 April 2013 and it continues to commission against these contracts, as previously.

NHS England commenced the review of stereotactic radiosurgery in August 2013 and expects a final report to be considered at its specialised commissioning oversight group, post a public consultation period, in October 2014.

NHS England will consult with the public, patients and professionals and take account of those views when taking a final decision. A summary of the responses received will be included when publishing the final report post the consultation period.

The below Parliamentary question was asked by Tessa Munt on 2014-06-13.

To ask the Secretary of State for Health, with reference to the Answer of 24 March 2014, Official Report, column 132W, on radiotherapy, what reports he has received on the reasons NHS England has paid for Gamma Knife treatment at University College Hospital London (UCHL) for a patient with an acoustic neuroma referred to UCHL from Bournemouth and Poole Hospital.

Jane Ellison

For reasons of patient confidentiality, it is not possible to comment explicitly on either case referred to. However, any primary care trust authorisations made for the gamma knife prior to 1 April 2013 were honoured by NHS England and the invoice associated with the agreed work was paid. University College London Hospitals (UCLH) were required to forward any referrals made after 1 April 2013 to NHS England, along the prescribed pathway, in accordance with the contract between the two. No invoices for work carried out by Queen’s Square Radiotherapy Centre at its own risk on behalf of UCLH have been paid by NHS England for referrals after 1 April 2013.

The below Parliamentary question was asked by Tessa Munt on 2014-05-01.

To ask the Secretary of State for Health, if he will publish (a) a list of all stakeholders who have so far been consulted by NHS England as part of its review into stereotactic radiosurgery and (b) the responses from those stakeholders.

Jane Ellison

All existing contracts for stereotactic radiotherapy services were transferred to NHS England on 1 April 2013 and it continues to commission against these contracts, as previously.

NHS England commenced the review of stereotactic radiosurgery in August 2013 and expects a final report to be considered at its specialised commissioning oversight group, post a public consultation period, in October 2014.

NHS England will consult with the public, patients and professionals and take account of those views when taking a final decision. A summary of the responses received will be included when publishing the final report post the consultation period.

The below Parliamentary question was asked by Tessa Munt on 2014-05-01.

To ask the Secretary of State for Health, when NHS England began its review into the future of stereotactic radiosurgery; and when its plans to complete the review.

Jane Ellison

All existing contracts for stereotactic radiotherapy services were transferred to NHS England on 1 April 2013 and it continues to commission against these contracts, as previously.

NHS England commenced the review of stereotactic radiosurgery in August 2013 and expects a final report to be considered at its specialised commissioning oversight group, post a public consultation period, in October 2014.

NHS England will consult with the public, patients and professionals and take account of those views when taking a final decision. A summary of the responses received will be included when publishing the final report post the consultation period.